Advances in the research of melatonin in autism spectrum disorders: Literature review and new perspectives

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 20508-20542

  Tordjman, Sylvie ^a,b   Najjar, Imen ^a   Bellissant, Eric ^c   Anderson, George M ^d,e   Barburoth, Marianne ^b   Cohen, David ^f   Jaafari, Nemat ^g   Schischmanoff, Olivier ^h,i   Fagard, Rémi ^h,i   Lagdas, Enas ^a   Kermarrec, Solenn ^a   Ribardiere, Sophie ^a   Botbol, Michel ^j   Fougerou, Claire ^c   Bronsard, Guillaume ^k   Vernay Leconte, Julie ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g POITIERS UNIVERSITY HOSPITAL   (France)

^h UNIVERSITÉ PARIS 13   (France)

ⁱ AVICENNE HOSPITAL   (France)

^j UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^k AIX MARSEILLE UNIVERSITY   (France)

more..

Author keywords

Autism spectrum disorders; Biological clocks; Circadian rhythm; Melatonin; Social communication; Stereotyped behaviors; Synchrony

Indexed keywords

MELATONIN; PINEAL BODY HORMONE; PLACEBO; SEROTONIN;

AGITATION; ASMT GENE; AUTISM; BEHAVIOR DISORDER; CIRCADIAN RHYTHM; COMMUNICATION DISORDER; COMPULSION; CONTROLLED RELEASE FORMULATION; DAYTIME SOMNOLENCE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ENTEROPATHY; ENURESIS; EPILEPSY; FATIGUE; GENE; HEADACHE; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE SYNTHESIS; HUMAN; INFECTION; INFLUENZA; LANGUAGE DEVELOPMENT; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; NIGHT SLEEP; NOCTURNAL ENURESIS; NONHUMAN; NONVERBAL COMMUNICATION; PARASOMNIA; PATHOPHYSIOLOGY; REVIEW; SIDE EFFECT; SLEEP DISORDER; SLEEP PATTERN; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE; SOCIAL ADAPTATION; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SOMNOLENCE; STEREOTYPY; TREATMENT RESPONSE; VERBAL COMMUNICATION;

ANIMALS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMMUNICATION DISORDERS; HUMANS; MELATONIN;

EID: 84885914118     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141020508     Document Type: Review

References (161)

1. Pandi-Perumal, S.R.; Trakht, I.; Spence, D.W.; Srinivasan, V.; Dagan, Y.; Cardinali, D.P. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. Nat. Clin. Pract. Neurol. 2008, 4, 436-447.
2. Lerner, A.B.; Case, J.D.; Takahashi, Y. Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J. Biol. Chem. 1960, 235, 1992-1997.
3. Cardinali, D.P. Melatonin. A mammalian pineal hormone. Endocr. Rev. 1981, 2, 327-346.
4. Stehle, J.H.; von Gall, C.; Korf, H.W. Melatonin: A clock-output, a clock-input. J. Neuroendocrinol. 2003, 15, 383-389.
5. Klein, D.C. Arylalkylamine N-acetyltransferase: "The Timezyme". J. Biol. Chem. 2007, 282, 4233-4237.
6. Simonneaux, V.; Ribelayga, C. Generation of the melatonin endocrine message in mammals: A review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol. Rev. 2003, 55, 325-395.
7. Dubocovich, M.L.; Delagrange, P.; Krause, D.N.; Sugden, D.; Cardinali, D.P.; Olcese, J. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol. Rev. 2010, 62, 343-380.
8. Cardinali, D.P.; Golombek, D.A.; Rosenstein, R.E.; Cutrera, R.A.; Esquifino, A.I. Melatonin site and mechanism of action: Single or multiple? J. Pineal Res. 1997, 23, 32-39.
9. McCarter, S.J.; Boswell, C.L.; St Louis, E.K.; Dueffert, L.G.; Slocumb, N.; Boeve, B.F.; Silber, M.H.; Olson, E.J.; Tippmann-Peikert, M. Treatment outcomes in REM sleep behavior disorder. Sleep Med. 2013, 14, 237-242.
10. Russcher, M.; Koch, B.C.; Nagtegaal, J.E.; van Ittersum, F.J.; Pasker-de Jong, P.C.; Hagen, E.C.; van Dorp, W.T.; Gabreëls, B.; Wildbergh, T.X.; van der Westerlaken, M.M.; et al. Long-term effects of melatonin on quality of life and sleep in hemodialysis patients (Melody study): A randomized controlled trial. Br. J. Clin. Pharmacol. 2013, doi:10.1111/bcp.12093.
11. Appleton, R.E.; Gringras, P. Melatonin: Helping to MEND impaired sleep. Arch. Dis. Child 2013, 98, 216-217.
12. Comai, S.; Ochoa-Sanchez, R.; Gobbi, G. Sleep-wake characterization of double MT(1)/MT(2) receptor knockout mice and comparison with MT(1) and MT(2) receptor knockout mice. Behav. Brain Res. 2013, 243, 231-238.
13. Sánchez-Barceló, E.J.; Mediavilla, M.D.; Tan, D.X.; Reiter, R.J. Clinical uses of melatonin: Evaluation of human trials. Curr. Med. Chem. 2010, 17, 2070-2095.
14. Kireev, R.A.; Tresguerres, A.C.; Garcia, C.; Ariznavarreta, C.; Vara, E.; Tresguerres, J.A. Melatonin is able to prevent the liver of old castrated female rats from oxidative and pro-inflammatory damage. J. Pineal Res. 2008, 45, 394-402.
15. Pohanka, M.; Sobotka, J.; Jilkova, M.; Stetina, R. Oxidative stress after sulfur mustard intoxication and its reduction by melatonin: Efficacy of antioxidant therapy during serious intoxication. Drug Chem. Toxicol. 2011, 34, 85-91.
16. Liang, Y.L.; Zhang, Z.H.; Liu, X.J.; Liu, X.Q.; Tao, L.; Zhang, Y.F.; Wang, H.; Zhang, C.; Chen, X.; Xu, D.X. Melatonin protects against apoptosis-inducing factor (AIF)-dependent cell death during acetaminophen-induced acute liver failure. PLoS One 2012, 7, 51911.
17. Jang, S.S.; Kim, H.G.; Lee, J.S.; Han, J.M.; Park, H.J.; Huh, G.J.; Son, C.G. Melatonin reduces X-ray radiation-induced lung injury in mice by modulating oxidative stress and cytokine expression. Int. J. Radiat. Biol. 2013, 89, 97-105.
18. Tresguerres, J.A.; Kireev, R.; Forman, K.; Cuesta, S.; Tresguerres, A.F.; Vara, E. Effect of chronic melatonin administration on several physiological parameters from old wistar rats and samp8 mice. Curr. Aging Sci. 2012, 5, 242-253.
19. Anisimov, V.N.; Vinogradova, I.A.; Panchenko, A.V.; Popovich, I.G.; Zabezhinski, M.A. Light-at-night-induced circadian disruption, cancer and aging. Curr. Aging Sci. 2012, 5, 170-177.
20. Corrales, A.; Martínez, P.; García, S.; Vidal, V.; García, E.; Flórez, J.; Sanchez-Barceló, E.J.; Martínez-Cué, C.; Rueda, N. Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome. J. Pineal Res. 2013, 54, 346-358.
21. Tchekalarova, J.; Petkova, Z.; Pechlivanova, D.; Moyanova, S.; Kortenska, L.; Mitreva, R.; Lozanov, V.; Atanasova, D.; Lazarov, N.; Stoynev, A. Prophylactic treatment with melatonin after status epilepticus: Effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy. Epilepsy Behav. 2013, 27, 174-187.
22. Cardinali, D.P.; Vigo, D.E.; Olivar, N.; Vidal, M.F.; Furio, A.M.; Brusco, L.I. Therapeutic application of melatonin in mild cognitive impairment. Am. J. Neurodegener. Dis. 2012, 1, 280-291.
23. Pevet, P.; Bothorel, B.; Slotten, H.; Saboureau, M. The chronobiotic properties of melatonin. Cell Tissue Res. 2002, 309, 183-191.
24. Slotten, H.A.; Krekling, S.; Sicard, B.; Pévet, P. Daily infusion of melatonin entrains circadian activity rhythms in the diurnal rodent Arvicanthis ansorgei. Behav. Brain Res. 2002, 133, 11-19.
25. Slotten, H.A.; Pitrosky, B.; Krekling, S.; Pévet, P. Entrainment of circadian activity rhythms in rats to melatonin administered at T cycles different from 24 hours. Neurosignals 2002, 11, 73-80.
26. Pevet, P.; Challet, E. Melatonin: Both master clock output and internal time-giver in the circadian clocks network. J. Physiol. 2011, 105, 170-182.
27. Johnston, J.D.; Messager, S.; Barrett, P.; Hazlerigg, D.G. Melatonin action in the pituitary: Neuroendocrine synchronizer and developmental modulator? J. Neuroendocrinol. 2003, 15, 405-408.
28. Stehle, J.H.; von Gall, C.; Korf, H.W. Organisation of the circadian system in melatonin-proficient C3H and melatonin-deficient C57BL mice: A comparative investigation. Cell Tissue Res. 2002, 309, 173-182.
29. Von Gall, C.; Garabette, M.L.; Kell, C.A.; Frenzel, S.; Dehghani, F.; Schumm-Draeger, P.M.; Weaver, D.R.; Korf, H.W.; Hastings, M.H.; Stehle, J.H. Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin. Nat. Neurosci. 2002, 5, 234-238.
30. Messager, S.; Garabette, M.L.; Hastings, M.H.; Hazlerigg, D.G. Tissue-specific abolition of Per1 expression in the pars tuberalis by pinealectomy in the Syrian hamster. Neuroreport. 2001, 12, 579-582.
31. Agez, L.; Laurent, V.; Guerrero, H.Y.; Pévet, P.; Masson-Pévet, M.; Gauer, F. Endogenous melatonin provides an effective circadian message to both the suprachiasmatic nuclei and the pars tuberalis of the rat. J. Pineal Res. 2009, 46, 95-105.
32. Logan, R.W.; Wynne, O.; Levitt, D.; Price, D.; Sarkar, D.K. Altered circadian expression of cytokines and cytolytic factors in splenic natural killer cells of per1(-/-) mutant mice. J. Interferon Cytokine Res. 2013, 33, 108-114.
33. Zeman, M.; Herichova, I. Melatonin and clock genes expression in the cardiovascular system. Front Biosci. (Schol Ed) 2013, 5, 743-753.
34. Alonso-Vale, M.I.; Andreotti, S.; Mukai, P.Y.; Borges-Silva, C.D.; Peres, S.B.; Cipolla-Neto, J.; Lima, F.B. Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J. Pineal Res. 2008, 45, 422-429.
35. Kennaway, D.J.; Owens, J.A.; Voultsios, A.; Wight, N. Adipokines and adipocyte function in Clock mutant mice that retain melatonin rhythmicity. Obesity (Silver Spring) 2012, 20, 295-305.
36. Delezie, J.; Dumont, S.; Dardente, H.; Oudart, H.; Gréchez-Cassiau, A.; Klosen, P.; Teboul, M.; Delaunay, F.; Pévet, P.; Challet, E. The nuclear receptor REV-ERBα is required for the daily balance of carbohydrate and lipid metabolism. FASEB J. 2012, 26, 3321-3335.
37. Xiang, S.; Mao, L.; Duplessis, T.; Yuan, L.; Dauchy, R.; Dauchy, E.; Blask, D.E.; Frasch, T.; Hill, S.M. Oscillation of clock and clock controlled genes induced by serum shock in human breast epithelial and breast cancer cells: Regulation by melatonin. Breast Cancer (Auckl). Epub. 2012, 6, 137-150.
38. Torres-Farfan, C.; Mendez, N.; Abarzua-Catalan, L.; Vilches, N.; Valenzuela, G.J.; Seron-Ferre, M. A circadian clock entrained by melatonin is ticking in the rat fetal adrenal. Endocrinology 2011, 152, 1891-1900.
39. Brodsky, V.Y.; Zvezdina, N.D. Melatonin as the most effective organizer of the rhythm of protein synthesis in hepatocytes in vitro and in vivo. Cell Biol. Int. 2010, 34, 1199-1204.
40. Chakravarty, S.; Rizvi, S.I. Circadian modulation of human erythrocyte plasma membrane redox system by melatonin. Neurosci. Lett. 2012, 518, 32-35.
41. Axelrod, J. The pineal gland: A neurochemical transducer. Science 1974, 184, 1341-1348.
42. Zhdanova, I.; Lynch, H.; Wurtman, R. Melatonin: A sleep-promoting hormone. Sleep 1997, 20, 899-907.
43. Arendt, J. Melatonin and human rhythms. Chronobiol. Int. 2006, 29, 21-37.
44. Niles, L.P.; Armstrong, K.J.; Rincón Castro, L.M.; Dao, C.V.; Sharma, R.; McMillan, C.R.; Doering, L.C.; Kirkham, D.L. Neural stem cells express melatonin receptors and neurotrophic factors: Colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci. 2004, 5, 41.
45. Iwasaki, S.; Nakazawa, K.; Sakai, J.; Kometani, K.; Iwashita, M.; Yoshimura, Y.; Maruyama, T. Melatonin as a local regulator of human placental function. J. Pineal. Res. 2005, 39, 261-265.
46. De Faria Poloni, J.; Feltes, B.C.; Bonatto, D. Melatonin as a central molecule connecting neural development and calcium signaling. Funct. Integr. Genomics 2011, 11, 383-388.
47. Glickman, G. Circadian rhythms and sleep in children with autism. Neurosci. Biobehav. Rev. 2010, 34, 755-768.
48. Honomichl, R.D.; Goodlin-Jones, B.L.; Burnham, M.; Gaylor, E.; Anders, T. Sleep patterns of children with pervasive developmental disorders. J. Autism Dev. Disord. 2002, 32, 553-561.
49. Hoshino, Y.; Wanatabe, H.; Yashima, Y.; Kaneko, M.; Kumashiro, H. An investigation on the sleep disturbance of autistic children. Folia Psychiatr. Neurol. Jpn. 1984, 38, 45-51.
50. Johnson, C.R. Sleep problems in children with mental retardation and autism. Child Adolesc. Psychiatr. Clin. N. Amer. 1996, 5, 673-683.
51. Patzold, L.M.; Richdale, A.L.; Tonge, B.J. An investigation into sleep characteristics of children with autism and Asperger's disorder. J. Paed. Child Health 1998, 34, 528-533.
52. Richdale, A.L.; Prior, M.R. The sleep-wake rhythm in children with autism. Eur. Child Adolesc. Psychiatry 1995, 4, 175-186.
53. Richdale, A.L. Sleep problems in autism: Prevalence, cause, and intervention. Dev. Med. Child Neurol. 1999, 41, 60-66.
54. Rutter, M. Concepts of autism-A review of research. J. Child Psychol. Psychiatry 1968, 9, 1-25.
55. Schreck, K.A.; Mullick, J.A. Parental reports of sleep problems in children with autism. J. Autism Dev. Disord. 2000, 30, 127-135.
56. Anderson, G.M. Genetics of childhood disorders: XLV. Autism, Part 4: Serotonin in autism. J. Amer. Acad. Child Adolesc. Psychiatry 2002, 41, 1513-1516.
57. Nakamura, K.; Sekine, Y.; Ouchi, Y.; Tsujii, M.; Yoshikawa, E.; Futatsubashi, M.; Tsuchiya, K.J.; Sugihara, G.; Iwata, Y.; Suzuki, K.; et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch. Gen. Psychiatry 2010, 67, 59-68.
58. Tordjman, S.; Anderson, G.M.; Pichard, N.; Charbuy, H.; Touitou, Y. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol. Psychiatry 2005, 57, 134-138.
59. Tordjman, S.; Anderson, G.M.; Bellissant, E.; Botbol, M.; Charbuy, H.; Camus, F.; Graignic, R.; Kermarrec, S.; Fougerou, C.; Cohen, D.; Touitou, Y. Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology 2012, 37, 1990-1997.
60. Miyamoto, A.; Oki, J.; Takahashi, S.; Okuno, A. Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome. Brain Dev. 1999, 21, 59-62.
61. Yamashita, Y.; Matsuishi, T.; Murakami, Y.; Kato, H. Sleep disorder in Rett syndrome and melatonin treatment. Brain Dev. 1999, 21, 570.
62. Reiter, R.J.; Barlow-Walden, L.; Poeggeler, B.; Heiden, S.M.; Clayton, R.J. Twenty-four hour urinary excretion of 6-hydroxymelatonin sulfate in Down syndrome subjects. J. Pineal Res. 1996, 20, 45-50.
63. Gould, E.L.; Loesch, D.Z.; Martin, M.J.; Hagerman, R.J.; Amstrong, S.M.; Huggins, R.M. Melatonin profiles and sleep characteristics in boys with fragile X syndrome: A preliminary study. Am. J. Med. Genet. 2000, 95, 307-315.
64. Ritvo, E.R.; Ritvo, R.; Yuliwer, A.; Brothers, A.; Freeman, B.J.; Plotkin, S. Elevated daytime melatonin concentration in autism. Eur. Child Adolesc. Psychiatry 1993, 2, 75-78.
65. Nir, I.; Meir, D.; Zilber, N.; Knobler, H.; Hadjez, J.; Lerner, Y. Brief report: Circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J. Autism Dev. Disord. 1995, 25, 641-654.
66. Kulman, G.; Lissoni, P.; Rovelli, F.; Roselli, M.G.; Brivio, F.; Sequeri, P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol. Lett. 2000, 20, 31-34.
67. Melke, J.; Goubran Botros, H.; Chaste, P.; Betancur, C.; Nygren, G.; Anckarssater, H.; Rastam, M.; Stahlberg, O.; Gillberg, I.C.; Delorme, R.; et al. Abnormal melatonin synthesis in autism spectrum disorder. Mol. Psychiatry 2008, 13, 90-98.
68. Mulder, E.J.; Anderson, G.M.; Kemperman, R.F.J.; Oosterloo-Duinkerken, A.; Minderaa, R.B.; Kema, I.P. Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals. Neuropsychobiology 2010, 61, 27-32.
69. Botros, H.G.; Legrand, P.; Pagan, C.; Bondet, V.; Weber, P.; Ben-Abdallah, M.; Lemière, N.; Huguet, G.; Bellalou, J.; Maronde, E.; et al. Crystal structure and functional mapping of human ASMT, the last enzyme of the melatonin synthesis pathway. J. Pineal Res. 2013, 54, 46-57.
70. Cai, G.; Edelmann, L.; Goldsmith, J.E.; Cohen, N.; Nakamine, A.; Reichert, J.G.; Hoffman, E.J.; Zurawiecki, D.M.; Silverman, J.M.; Hollander, E.; et al. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: Efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med. Genomics 2008, 1, 50.
71. Toma, C.; Rossi, M.; Sousa, I.; Blasi, F.; Bacchelli, E.; Alen, R.; Vanhala, R.; Monaco, A.P.; Järvelä, I.; Maestrini, E. International molecular genetic study of autism consortium. Is ASMT a susceptibility gene for autism spectrum disorders? A replication study in European populations. Mol. Psychiatry 2007, 12, 977-979.
72. Jonsson, L.; Ljunggren, E.; Bremer, A.; Pedersen, C.; Landen, M.; Thuresson, K.; Giacobini, M.; Melke, J. Mutation screening of melatonin-related genes in patients with autism spectrum disorders. BMC Med. Genomics 2010, 3, 10.
73. Chaste, P.; Clement, N.; Mercati, O.; Guillaume, J.L.; Delorme, R.; Botros, H.G.; Pagan, C.; Périvier, S.; Scheid, I.; Nygren, G.; et al. Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population. PLoS One 2010, 5, e11495.
74. Gardener, H.; Spiegelman, D.; Buka, S.L. Perinatal and neonatal risk factors for autism: A comprehensive meta-analysis. Pediatrics 2011, 128, 344-355.
75. Revell, V.L.; Skene, D.J. Light-induced melatonin suppression in humans with polychromatic and monochromatic light. Chronobiol. Int. 2007, 24, 1125-1135.
76. Zapella, M. Autism and hypomelanosis of Ito in twins. Dev. Med. Child Neurol. 1993, 35, 826-832.
77. Tordjman, S.; Anderson, G.M.; McBride, P.A.; Hertzig, M.; Snow, M.; Hall, L.; Ferrari, P.; Cohen, D.J. Plasma beta-endorphin, adrenocorticotropin hormone and cortisol in autism. J. Child Psychol. Psychiatry 1997, 38, 705-716.
78. Doyen, C.; Mighiu, D.; Kaya, K.; Colineaux, C.; Beaumanoir, C.; Mouraeff, Y.; Rieu, C.; Paubel, P.; Contejean, Y. Melatonin in children with autistic spectrum disorders: Recent and practicaldata. Eur. Child Adolesc. Psychiatry 2011, 20, 231-239.
79. Guénolé, F.; Godbout, R.; Nicolas, A.; Franco, P.; Claustrat, B.; Baleyte, J.M. Melatonin for disordered sleep in individuals with autism spectrum disorders: Systematic review and discussion. Sleep Med. Rev. 2011, 15, 379-387.
80. Rossignol, D.A.; Frye, R.E. Melatonin in autism spectrum disorders: A systematic review and meta-analysis. Dev. Med. Child Neurol. 2011, 53, 783-792.
81. Horrigan, J.P.; Barnhill, L.J. More on melatonin. J. Am. Acad. Child Adolesc. Psychiatry 1997, 36, 1014.
82. Hayashi, E. Effect of melatonin on sleep-wake rhythm: The sleep diary of an autistic male. Psychiatry Clin. Neurosci. 2000, 54, 383-384.
83. Jan, J.E.; Freeman, R.D.; Wasdell, M.B.; Bomben, M.M. A child with severe night terrors and sleep-walking responds to melatonin therapy. Dev. Med. Child Neurol. 2004, 46, 789.
84. Gupta, R.; Hutchins, J. Melatonin: A pancea for desperate parents? (Hype or truth). Arch. Dis. Child 2005, 90, 986-987.
85. Andersen, I.M.; Kaczmarska, J.; McGrew, S.G.; Malow, B.A. Melatonin for insomnia in children with autism spectrum disorders. J. Child Neurol. 2008, 23, 482-485.
86. Galli-Carminati, G.; Deriaz, N.; Bertschy, G. Melatonin in treatment of chronic sleep disorders in adults with autism: Retrospective study. Swiss Med. Weekly 2009, 139, 293-296.
87. Jan, J.E.; Espezel, H.; Appleton, R.E. The treatment of sleep disorders with melatonin. Dev. Med. Child Neurol. 1994, 36, 97-107.
88. Ishizaki, A.; Sugama, M.; Takeuchi, N. Usefulness of melatonin for developmental sleep and emotional/behaviour disorders-studies of melatonin trial on 50 patients with developmental disorders. No To Hattatsu 1999, 31, 428-437.
89. Paavonen, E.J.; Nieminen-von Wendt, T.; Vanhala, R.; Aronen, E.T.; von Wendt, L. Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. Child Adolesc. Psychopharmacol. 2003, 13, 83-95.
90. Giannotti, F.; Cortesi, F.; Cerquiglini, A.; Bernabei, P. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. J. Autism Dev. Disord. 2006, 36, 741-752.
91. De Leersnyder, H.; Zisapel, N.; Laudon, M. Prolonged-release melatonin for children with neurodevelopmental disorders. Pediatr. Neurol. 2011, 45, 23-26.
92. Malow, B.; Adkins, K.; McGrew, S.; Wang, L.; Goldman, S.; Fawkes, D.; Burnette, C. Melatonin for sleep in children with autism: A controlled trial examining dose, tolerability and outcomes. J. Autism Dev. Disord. 2011, 42, doi:10.1007/s10803-011-1418-3.
93. MacArthur, A.J.; Budden, S.S. Sleep dysfonction in Rett syndrome: A trial of exogenous melatonin treatment. Dev. Med. Child Neurol. 1998, 40, 186-192.
94. Garstang, J.; Wallis, M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev. 2006, 32, 585-589.
95. Wasdell, M.B.; Jan, J.E.; Bomben, M.M.; Freeman, R.D.; Rietveld, W.J.; Tai, J.; Hamilton, D.; Weiss, M.D. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J. Pineal Res. 2008, 44, 57-64.
96. Wirojanan, J.; Jacquemont, S.; Diaz, R.; Bacalman, S.; Anders, T.F.; Hagerman, R.J.; Goodlin-Jones, B.L. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J. Clin. Sleep Med. 2009, 5, 145-150.
97. Wright, B.; Sims, D.; Smart, S.; Alwazeer, A.; Alderson-Day, B.; Allgar, V.; Whitton, C.; Tomlinson, H.; Bennett, S.; Jardine, J.; et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour. Management strategies: A randomised controlled crossover trial. J. Autism Dev. Disord. 2011, 41, 175-184.
98. Cortesi, F.; Giannotti, F.; Sebastiani, T.; Panunzi, S.; Valente, D. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: A randomized placebo-controlled trial. J. Sleep Res. 2012, 21, 700-709.
99. Gringas, P.; Gamble, C.; Jones, A.P.; Wiggs, L.; Williamson, P.R.; Sutcliffe, A.; Montgomery, P.; Whitehouse, W.P.; Choonara, I.; Allport, T.; et al. Melatonin for sleep problems in children with neurodevelopmental disorders: Randomised double masked placebo controlled trial. BMJ 2012, 345, 1-16.
100. Jan, J.E.; O'Donnel, M.E. Use of melatonin in the treatment of paediatric sleep disorders. J. Pineal Res. 1996, 21, 193-199.
101. Jan, J.E.; Connolly, M.B.; Hamilton, D.; Freeman, R.D.; Laudon, M. Melatonin treatment of non-epileptic myoclonus in children. Dev. Med. Child Neurol. 1999, 41, 255-259.
102. Phillips, L.; Appleton, R.E. Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev. Med. Child Neurol. 2004, 46, 771-775.
103. Braam, W.; Smits, M.G.; Didden, R.; Korzilius, H.; van Geijlswijk, M.; Curfs, L.M.G. Exogenous melatonin for sleep problems in individuals with intellectual disability: A meta-analysis. Dev. Med. Child Neurol. 2009, 51, 340-349.
104. Reading, R. Melatonin in autism spectrum disorders: A systematic review and meta-analysis. Child Care Health Dev. 2012, 38, 301-302.
105. Guénolé, F.; Baleyte, J.M. Meta-analysing the effectiveness of melatonin for sleep-disturbed individuals with autism spectrum conditions: Should Rett syndrome be included? Dev. Med. Child Neurol. 2011, 53, 1063.
106. Guénolé, F.; Baleyte, J.M. Effects of melatonin should be studied separately in each neurodevelopmental disorder and with specific sleep diagnoses. Pediatr. Neurol. 2012, 46, 60.
107. Jan, J.E.; Freeman, R.D. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: What have we learned in the last decade? Dev. Med. Child Neurol. 2004, 46, 776-782.
108. Lord, C. What is melatonin? Is it a useful treatment for sleep problems in autism? J. Autism Dev. Disord. 1998, 28, 345-346.
109. Jan, J.; Freeman, R.D.; Fast, D.K. Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Med. Child Neurol. Dev. 1999, 41, 491-500.
110. Braam, W.; van Geijlswijk, I.; Keijzer, H.; Smits, M.G.; Didden, R.; Curfs, L.M. Loss of response to melatonin treatment is associated with slow melatonin metabolism. J. Inte llect. Disabil. Res. 2010, 54, 547-555.
111. Braam, W.; Keijzer, H.; Struijker Boudier, H.; Didden, R.; Smits, M.; Curfs, L. CYP1A2 polymorphisms in slow melatonin metabolisers: A possible relationship with autism spectrum disorder? J. Intellect. Disabil. Res. 2012, 23, doi:10.1111/j.1365-2788.2012.01595.x.
112. Touitou, Y. Human aging and melatonin. Clinical relevance. Exp. Gerontol. 2001, 36, 1083-1100.
113. Cavallo, A.; Ritschel, W.A. Pharmacokinetics of melatonin in human sexual maturation. J. Clin. Endocrinol. Metab. 1996, 81, 1882-1886.
114. Lord, C. Diagnostic Instruments in Autism Spectrum Disorders in Handbook of Autism and Pervasive Developmental Disorders, 2nd ed.; Cohen, D.J., Volkmar, F.R., Eds.; John Wiley and Sons INC: New York, NY, USA, 1997.
115. Quine, L. Sleep problems in children with mental handicap. J. Ment. Defic. Res. 1991, 35, 269-290.
116. Kotagal, S.; Broomall, E. Sleep in children with autism spectrum disorder. J. Pediatr. Neurol. 2012, 47, 242-251.
117. Rosenberg, J.; Push, K.; Dietrich, R.; Cajochen, C. The tick-tock of language: Is language processing sensitive to circadian rhythmicity and elevated sleep pressure? Chronobiol Int. 2009, 26, 974-991.
118. Jansen, R.; Metzdorf, R.; van der Roest, M.; Fusani, L.; Ter Maat, A.; Gahr, M. Melatonin affects the temporal organization of the song of the zebra finch. FASEB J. 2005, 19, 848-850.
119. Hu, V.W.; Sarachana, T.; Kim, K.S.; Nguyen, A.; Kulkarni, S.; Steinberg, M.E.; Luu, T.; Lai, Y.; Lee, N.H. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: Evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2009, 2, 78-97.
120. Boucher, J. Lost in a Sea of Time: Time Parsing and Autism; McCormack, T., Hoerl, C., Eds.; Oxford University Press: Oxford, UK, 2001.
121. Wimpory, D.; Nicholas, B.; Nash, S. Social timing clock genes and autism: A new hypothesis. J. Intellect. Disabil. Res. 2002, 46, 352-358.
122. Molenaar, P.C.M.; Campbell, C.G. The new person-specific paradigm in psychology. Curr. Dir. Psychol. Sci. 2009, 18, 112-117.
123. Brown, R.; Hobson, R.P.; Lee, A.; Stevenson, J. Are there "autistic-like" features in congenitally blind children? J. Child Psychol. Psychiatry 1997, 38, 693-703.
124. Donaldson, A.I.; Heavner, K.S.; Zwolan, T.A. Measuring progress in children with autism spectrum disorder who have cochlear implants Arch. Otolaryngol. 2004, 130, 666-671.
125. Guedeney, A.; Guedeney, N.; Tereno, S.; Dugravier, R.; Greacen, T.; Welniarz, B.; Saias, T.; Tubach, F.; the CAPEDP Study Group. Infant rhythms versus parental time: Promoting parent-infant synchrony. J. Physiol. Paris 2011, 105, 195-200.
126. Meltzoff, A.N.; Kuhl, P.K.; Movellan, J.; Sejnowski, T.J. Foundations for a new science of learning. Science 2009, 325, 284-288.
127. Kuhl, P.K. Early language acquisition: Cracking the speech code. Nat. Rev. Neurosci. 2004, 5, 831-843.
128. Goldstein, M.H.; King, A.P.; West, M.J. Social interaction shapes babbling: Testing parallels between birdsong and speech. Proc. Natl. Acad. Sci. USA 2003, 100, 8030-8035.
129. Chaby, L.; Chetouani, M.; Plaza, M.; Cohen, D. Exploring multimodal social-emotional behaviors in autism spectrum disorders. In Proceedings of the 2012 ASE/IEEE International Conference on Social Computing and 2012 ASE/IEEE International Conference on Privacy, Security, Risk and Trust; IEEE Computer Society: Washington, DC, USA, 2012,; pp. 950-954.
130. Delaherche, E.; Chetouani, M.; Mahdhaoui, A.; Saint-Georges, C.; Viaux, S.; Cohen, D. Interpersonal synchrony: A survey of evaluation methods across disciplines. IEEE Trans. Affect. Comput. 2012, 3, 349-365.
131. Crown, C.L.; Feldstein, S.; Jasnow, M.D.; Beebe, B.; Jaffe, J. The cross-modal coordination of interpersonal timing: Six-week-olds infants' gaze with adults' vocal behavior. J. Psycholinguist. Res. 2002, 31, 1-23.
132. Stormark, K.M.; Braarud, H.C. Infants' sensitivity to social contingency: A "double video" study of face-to-face communication between 2-and 4-month-olds and their mothers. Infant Behav. Dev. 2004, 27, 195-203.
133. Feldman, R. Parent-infant synchrony and the construction of shared timing; physiological precursors, developmental outcomes, and risk conditions. J. Child Psychol. Psychiatry 2007, 48, 329-354.
134. Dumas, G.J.; Nadel, R.; Soussignan, J.; Martinerie, L.; Garnero, L. Inter-brain synchronization during social interaction. PLoS One 2010, 5, 278-288.
135. Perry, A.; Troje, N.F.; Bentin, S. Exploring motor system contributions to the perception of social information: Evidence from EEG activity in the mu/alpha frequency range. Soc. Neurosci. 2010, 5, 272-284.
136. Champagne, F.; Diorio, J.; Sharma, S.; Meaney, M.J. Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors. Proc Natl. Acad. Sci. USA 2001, 98, 12736-12741.
137. Weisman, O.; Zagoory-Sharon, O.; Feldman, R. Oxytocin administration to parent enhances infant physiological and behavioral readiness for social engagement. Biol. Psychiatry 2012, 72, 982-989.
138. Saint-Georges, C.; Mahdhaoui, A.; Chetouani, M.; Cassel, R.; Laznik, M.C.; Apicella, F.; Muratori, P.; Maestro, S.; Muratori, F.; Cohen, D. Do parents recognize autistic deviant behavior long before diagnosis? Taking into account interaction using computational methods. PLoS One 2011, 6, e22393.
139. Werner, E.; Dawson, G.; Osterling, J.; Dinno, N. Brief report: Recognition of autism spectrum disorder before one year of age: A retrospective study based on home videotapes. J. Autism Dev. Disord. 2000, 30, 157-162.
140. Guinchat, V.; Chamak, B.; Bonniau, B.; Bodeau, N.; Perisse, D.; Cohen, D.; Danion, A. Very early signs of autism reported by parents include many concerns not specific to autism criteria. Res. Autism Spectr. Disord. 2012, 6, 589-601.
141. Zwaigenbaum, L.; Bryson, S.; Rogers, T.; Roberts, W.; Brian, J.; Szatmari, P. Behavioral manifestations of autism in the first year of life. Int. J. Dev. Neurosci. 2005, 23, 143-152.
142. Elsabbagh, M.; Johnson, M.H. Getting answers from babies about autism. Trends Cogn. Sci. 2010, 14, 81-87.
143. Cohen, D.; Cassel, R.S.; Saint-Georges, C.; Mahdhaoui, A.; Laznik, M.C.; Apicella, F.; Muratori, P.; Maestro, S.; Muratori, F.; Chetouani, M. Do motherese prosody and fathers' involvement in interacting facilitate social interaction in infants who will later develop autism? PLoS One 2013, 8, e61402.
144. Watanabe, K. Behavioral speed contagion: Automatic modulation of movement timing by observation of body movements. Cognition 2008, 106, 1514-1524.
145. Nettl, B. An Ethnomusicologist Contemplates Universals in Musical Sound and Musical Culture. In The Origins of Music; Wallin, N.L., Merker, B., Brown, S., Eds.; MIT Press: Cambridge, MA, USA, 2000; pp. 463-472.
146. Patel, A.D.; Iversen, J.R.; Bregman, M.R.; Schulz, I. Experimental evidence for synchronization to a musical beat in a nonhuman animal. Curr. Biol. 2009, 19, 827-830.
147. Trevarthen, C.; Aitken, K.J. Infant intersubjectivity: Research, theory, and clinical applications. J. Child Psychol. Psychiatry 2001, 421, 3-48.
148. Feldman, R. Parent-infant synchrony biological foundations and developmental outcomes. Curr. Dir. Psychol. Sci. 2007, 16, 340-345.
149. Winkler, I.; Háden, G.P.; Ladinig, O.; Sziller, I.; Honing, H. Newborn infants detect the beat in music. Proc. Natl. Acad. Sci. USA 2009, 106, 2468-2471.
150. Provasi, J.; Bobin-Begue, A. Spontaneous motor tempo and rhythmical synchronisation in 2-1/2 and 4-year-old children. Int. J. Behav. Dev. 2003, 27, 220-231.
151. Bobin-Bègue, A.; Provasi, J.; Marks, A.; Pouthas, V. Influence of an auditory tempo on the endogenous rhythm of non-nutritive sucking. Rev. Eur. Psychol. Appl. 2006, 56, 239-245.
152. Trevarthen, C.; Stuart Daniel, S. Disorganized rhythm and synchrony: Early signs of autism and Rett syndrome. Brain Dev. 2005, 27, S25-S34.
153. Winnicott, D.W. Collected Papers: Through Pediatrics to Psychoanalysis; Tavistock Publications: London, UK, 1958.
154. Tordjman, S. At the crossroads between psychoanalysis and neuroscience: The importance of subjectivity. J. Physiol. Paris 2010, 104, 232-242.
155. Casanova, A.; Saladin, M. L'évolution d'un cas d'autisme à l'âge adulte. In René Diatkine, une pensée en mouvement coordinated, [DVD]; Uhl, R., Ed.; Starfilm International: Paris, France, 2002; Volume 3.
156. Galloway, J. Helix through the looking-glass. New Sci. 1983, 27, 242-244.
157. Kanner, L. Austistic disturbances of affective contact. Nerv. Child 1943, 32, 217-253.
158. Amiet, C.; Gourfinkel-An, I.; Bouzamondo, A.; Tordjman, S.; Baulas, M.; Lechat, P.; Cohen, D.J. Epilepsy in autism is associated with intellectual disability and gender: Evidence from a meta-analysis. Biol. Psychiatry 2008, 64, 577-582.
159. Cloarec, F. Bîmaristans, lieux de folie et de sagesse. La folie et ses traitements dans les hôpitaux au moyen orient; l'Harmattan: Paris, France, 1998.
160. Bullinger, A. Le Concept D'instrumentation: Son intérêt pour L'approche des Différents Déficits. In Collection «Croissance de l'Enfant, Génèse de l'Homme»; Deleau, M., Ed.; Presses Universitaires de France: Paris, France, 1991.
161. Tordjman, S.; Kermarrec, S.; Cohen, D.; Rolland, A.C.; Gicquel, L.; Chevreuil, C.; Botbol, M.; Touitou, Y.; Ribardiere, S.; Bellissant, E. MELADOSE: Study of the dose-response relationship for melatonin in infantile autism. Neuropsy. Enf. Adolesc. 2013, in press.